Skip to content

Northwest Bancshares NWBI Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

PNC Financial Services logo
PNC Financial ServicesPNC
800M0.0%
M&T Bank logo
M&T BankMTB
Huntington Bancshares logo
Huntington BancsharesHBAN
Eastern Bankshares, Inc. logo
Eastern Bankshares, Inc.EBC
Center Bancorp logo
Center BancorpCNOB
First Merchants Corporation logo
First Merchants CorporationFRME

Other financials

Income statement

See full
Revenue$175.1M+12.1%
Net income$50.5M+16.3%
EPS (diluted)$0.340.0%

Balance sheet

See full
Cash & equivalents$286.7M-18.8%
Total debt$50.5M-79.8%
Total equity$1.9B+16.9%
Total assets$16.9B+17.0%

Cash flow

See full
Operating cash flow$73.9M-31.4%
CapEx$4.3M+136%
Free cash flow$69.6M-34.3%

Valuation

See full
Market cap$2.17B+21.0%
P/E16.3×+0.7×
P/S3.2×-0.1×

Profitability

See full
Net margin19.8%-1.2pp
FCF margin16.6%

Returns & leverage

See full
Return on equity7.5%+0.3pp
Debt / equity-0.1×

Where this comes from

Reported directly by Northwest Bancshares in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Northwest Bancshares’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Northwest Bancshares's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Northwest Bancshares's common stock, shares authorized (in shares)?
Northwest Bancshares (NWBI) reported common stock, shares authorized (in shares) of $500M in Q1 2026.
How has Northwest Bancshares's common stock, shares authorized (in shares) changed year-over-year?
Northwest Bancshares's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $500M to $500M.
What is the long-term trend for Northwest Bancshares's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Northwest Bancshares's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $500M to $500M.